Tolerance and withdrawal to anticonvulsant action of clonazepam: Role of nitric oxide

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 22, Issue 4, 2000, Pages 229-235

  Gupta, N ^a   Bhargava, V K ^a   Pandhi, P ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Anticonvulsant; Clonazepam; Electroshock; L arginine; N( ) nitro L arginine; Pentylenetetrazole (PTZ); Tolerance; Withdrawal

Indexed keywords

ARGININE; CLONAZEPAM; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG TOLERANCE; DRUG WITHDRAWAL; ELECTRIC SHOCK; ENZYME INHIBITION; EPILEPSY; EXCITABILITY; FEMALE; LONG TERM CARE; MALE; NONHUMAN; RAT; SEIZURE THRESHOLD;

EID: 0033920586     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2000.22.4.584455     Document Type: Article

References (29)

1. th Ed. McGraw Hill 1996, 461.
2. rd Ed. Raven Press: New York 1989, 765.
3. Brown, T.R., Penry, J.K. Benzodiazepines in the treatment of epilepsy. Epilepsia 1973, 14: 277-310.
4. Brown, T.R., Clonazepam - A review of new anticonvulsant drug. Arch Neurol 1976, 33: 326-32.
5. Masiand, R.L. A controlled trial of clonazepam in temporal lobe epilepsy. Acta Neurol Scand 1975, 60(Suppl): 49-54.
6. Doose, H. Zerebrale Anjalle im Kindesaiter. 6h Ed. Destin, Werk Carl Klinke, Hamburg 1980.
7. Woods, J.H., Katz, J.L., Winger, G. Benzodiazepines: Use, abuse and consequences. Pharmacol Rev 1992, 44: 151-347.
8. Tsuda, M., Suzuki, T., Misawa, M. Aggravation of DMCM-induced seizure by nitric oxide synthase inhibitors in mice. Life Sci 1997c, 60: 339-43.
9. Lei, S.Z., Pan, Z.H., Aggarwal, S.K., Chen, H.S.V. Hartman, J., Sucher, N.J., Lipton, S.A. Effect of nitric oxide production of the redox modulatory site of the NMDA receptor channel complex. Neuron 1992, 8: 1087-99.
10. Munzoni, O., Prezeau, L., Marin, P., Deshager, S., Bockaert, J., Faqnil, L. Nitric oxide induced blockade of NMDA receptors. Neuron 1992, 8: 653-62.
11. Kimball, A., Burnett, W. T., Doherty, D.G. Chemical protection against ionising radiation. Radiat Res 1957, 7: 1-12.
12. Rundtfeldt, C., Waz, P., Loscher, W. Anticonvulsant tolerance and withdrawal characteristics of BDZ receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil. J Pharmacol Exp Ther 1995, 275(2): 693-702.
13. Loscher, W., Honack, D., Noltin, B. The role of technical, biological and pharmacological factors in laboratory evaluation of anticonvulsant drugs III. Pentylenetetrazole seizures. Epilepsy Res 1991, 8: 171-89.
14. Swinyard, E.A. Laboratory evaluation of antiepileptic drugs. Review of laboratory methods. Epilepsia 1969, 10: 107-19.
15. Loscher, W., Fassbender, C.P., Nothing, B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res 1991, 9: 9-94.
16. A receptor function. J Pharmacol Exp Ther 1988, 246: 170-7.
17. Rosenberg, H.C., Tielz, E.I., Chui, T.H. Tolerance to anticonvulsant action of benzodiazepines. Relationship to decreased receptor density. Neuropharmacology 1995, 24: 639-44.
18. A receptor operated chloride channels. J Pharm Pharmacol 1992, 261: 395-402.
19. A/BDZ receptor complex. Mol Pharmacol 1990, 37: 37-43.
20. A/BDZ receptor/chloride channel coupling after acute and chronic BDZ treatment. Eur J Pharmacol 1989, 167: 57-69.
21. Dunworth, S.J., Stephans, D.N. Sensitization to repeated withdrawal in mice treated chronically with diazepam is blocked by NMDA receptor antagonist. Psychopharmacol 1998, 136: 308-10.
22. Stephen, D.N. A glutamatergic hypothesis of drug dependence-extrapolation from BDZ ligands. Behav Pharmacol 1999, 6: 425-46.
23. Remeteria, J.L., Bhatt, K. Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Paediatr 1977, 72: 123-26.
24. Turnbull, M.J., Walkins, J.W., Wheeler, H. Demonstration of withdrawal hyperexcitability following administration of benzodiazepines in rats and mice. Br J Pharmacol 1981, 72: 495p.
25. Tsuda, M., Suzuki, T., Misawa, M. NMDA receptor antagonists potently suppress spontaneously the withdrawal signs induced by discontinuation of long term diazepam treatment in Fischer 344 rats. Brain Res 1998a, 790: 82-90.
26. Tsuda, M., Chika, Y., Suzuki, T., Misawa, M. Upregulation of NMDA receptor subunit proteins in the cerebral cortex during diazepam withdrawal. Eur J Pharmacol 1998b, 341: R1-2.
27. Tsuda, M., Shimizu, N., Yajima, Y., Suzuki, T., Nfisawa, M. Role of nitric oxide in hypersusceptibility to pentylene-tetrazole-induced seizure in diazepam withdrawn mice. Eur J Pharmacol 1981, 344: 27-30.
28. Caccia, S., Gartinni, S. Benzodiazepine. In: Handbook of Experimental Pharmacology. H.H. Frey, D. Janz (Eds.). Springer Verlag: Berlin 1995, 74: 575-93.
29. Kirkby, R.D., Carroll, D.M., Grossman, A.B., Subramaniam, S. Factors determining the proconvulsant and anticonvulsant effects of inhibitors of nitric oxide synthase in rodents. Epilepsy Res 1996, 24: 91-100.